In the US, Rosiglitazone (rosiglitazone systemic) is a member of the drug class thiazolidinediones and is used to treat Diabetes - Type 2 and Nonalcoholic Fatty Liver Disease.
US matches:
- Rosiglitazone
- Rosiglitazone/Metformin
- Rosiglitazone and glimepiride
- Rosiglitazone and metformin
- Rosiglitazone Maleate
- Rosiglitazone Maleate/Glimepiride
- Rosiglitazone Maleate/Metformin Hydrochloride
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A10BG02
CAS registry number (Chemical Abstracts Service)
0122320-73-4
Chemical Formula
C18-H19-N3-O3-S
Molecular Weight
357
Therapeutic Category
Oral antidiabetic agent, insulin sensitizer, thiazolidinedione (glitazone)
Chemical Names
(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione (WHO)
(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion (IUPAC)
Foreign Names
- Rosiglitazonum (Latin)
- Rosiglitazon (German)
- Rosiglitazone (French)
- Rosiglitazona (Spanish)
Generic Names
- Rosiglitazone (OS: DCF, BAN)
- Rosiglitazone Maleate (OS: USAN)
- BRL 49653 C (IS: SmithKlineBeec)
Brand Names
- Avaglim (Rosiglitazone and Glimepiride)
Glaxo SmithKline, Spain; GlaxoSmithKline, Denmark; GlaxoSmithKline, Slovenia - Avandaglim (Rosiglitazone and Glimepiride)
GlaxoSmithKline, Russian Federation - Avandamet (Rosiglitazone and Metformin)
Glaxo SmithKline, Spain; GlaxoSmithKline, Denmark; GlaxoSmithKline, Peru; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, United States; SmithKline Beecham, Slovenia - Avandia
GlaxoSmithKline, Portugal; Smithkline Beechamn, Bulgaria - Diaglinex
Drugtech, Peru - Gaudil
Craveri, Argentina - Grexa Plus (Rosiglitazone and Glimepiride)
Farmindustria, Peru - Roglit
Gedeon Richter, Georgia; Gedeon Richter, Russian Federation - Romerol
Drug International, Bangladesh - Rosit
Delta, Bangladesh - Roziglitazon Pliva
Pliva, Croatia (Hrvatska) - Sensulin
Square, Bangladesh - Weigeluo
Sunve, China - Avaglim (Rosiglitazone and Glimepiride)
GlaxoSmithKline, Germany; GlaxoSmithKline, Hungary; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden; SmithKline Beecham, Austria - Avandamet (Rosiglitazone and Metformin)
Glaxo Wellcome, Bulgaria; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Sweden; GlaxoSmithKline, Thailand; SB Pharmco, United States; SmithKline Beecham, Austria - Avandaryl (Rosiglitazone and Glimepiride)
GlaxoSmithKline, Bahrain; GlaxoSmithKline, Canada; GlaxoSmithKline, Indonesia; GlaxoSmithKline, United States - Avandia
Glaxo SmithKline, Spain; GlaxoSmithKline, Antigua & Barbuda; GlaxoSmithKline, Netherlands Antilles; GlaxoSmithKline, Argentina; GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Bosnia & Herzegowina; GlaxoSmithKline, Barbados; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Bermuda; GlaxoSmithKline, Brazil; GlaxoSmithKline, Bahamas; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Colombia; GlaxoSmithKline, Costa Rica; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Dominican Republic; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Grenada; GlaxoSmithKline, Greece; GlaxoSmithKline, Guatemala; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Honduras; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Jamaica; GlaxoSmithKline, Cayman Islands; GlaxoSmithKline, Saint Lucia; GlaxoSmithKline, Sri Lanka; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Myanmar; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Nicaragua; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Panama; GlaxoSmithKline, Peru; GlaxoSmithKline, Philippines; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, El Salvador; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Trinidad & Tobago; GlaxoSmithKline, Taiwan; GlaxoSmithKline, United States; GlaxoSmithKline, Venezuela; GlaxoSmithKline, Vietnam; GlaxoSmithKline, South Africa; SmithKline Beecham, Austria; SmithKline Beecham, Slovenia - Diaben
Elea, Argentina - Dorosi
Domesco, Vietnam - Glimide
Beta, Argentina - Gliximina
Denver, Argentina - Gludex
Montpellier, Argentina - Hasandia
Hasan, Vietnam - Nor glitazon
Teramed, El Salvador - Rezult
Sun, India; Sun, Myanmar - Rezult-M (Rosiglitazone and Metformin)
Sun, India - Rosenda
Biofarma, Turkey - Rosicon
Glenmark, India; Glenmark, Sri Lanka; Glenmark, Myanmar - Rosicon-MF (Rosiglitazone and Metformin)
Glenmark, Myanmar - Rosiglit
Lazar, Argentina - Rosiglitazona Richet
Richet, Argentina - Rositaz
Abdi Ibrahim, Turkey - Rosvel
Sanovel, Turkey
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
IUPAC | International Union of Pure and Applied Chemistry |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment